Press Releases
- Business WireHemophilia B - Pipeline Insight, 2019 by Developmental Stage, Associated Indications, Route of Administration and Molecule Type - ResearchAndMarkets.comFebruary 15, 2019
- Globe NewswireCatalyst Biosciences Presents Updated Data from Its Phase 2/3 Trial of Subcutaneous Marzeptacog Alfa (Activated) in Individuals with Hemophilia A or B with Inhibitors at the 12th Annual EAHAD CongressFebruary 8, 2019
- Globe NewswireCatalyst Biosciences Announces Preclinical Proof-of-Concept Data of Gene Therapy Candidate CB 2679d-GT for the Treatment of Hemophilia BFebruary 6, 2019
- Business WireTakeda Announces Results from First-of-Its-Kind Phase IIIb/IV Trial PROPEL – a Randomized PK-Guided Prophylaxis Study Evaluating Higher Factor VIII Levels in Hemophilia A– at EAHAD 2019February 6, 2019
- Business WireTogether with Roche, Chugai Joins the World Federation of Hemophilia Humanitarian Aid ProgramFebruary 6, 2019
AP's Member Network: